New Possibility of Reversing Damage Caused by MS
Author: University of Cambridge
Damage caused by multiple sclerosis could be reversed by activating stem cells that can repair injury in the central nervous system.
Main DigestDamage caused by multiple sclerosis could be reversed by activating stem cells that can repair injury in the central nervous system, a study has shown.
Researchers from the Universities of Cambridge and Edinburgh have identified a mechanism essential for regenerating insulating layers - known as myelin sheaths - that protect nerve fibers in the brain. In additional studies in rodents, they showed how this mechanism can be exploited to make the brain's own stem cells better able to regenerate new myelin.
In multiple sclerosis, loss of myelin leads to the nerve fibers in the brain becoming damaged. These nerve fibers are important as they send messages to other parts of the body.
The scientists believe that this research will help in identifying drugs to encourage myelin repair in multiple sclerosis patients.
Professor Robin Franklin, Director of the MS Society's Cambridge Center for Myelin Repair at the University of Cambridge, said: "Therapies that repair damage are the missing link in treating multiple sclerosis. In this study we have identified a means by which the brain's own stem cells can be encouraged to undertake this repair, opening up the possibility of a new regenerative medicine for this devastating disease."
The study, funded by the MS Society in the UK and the National Multiple Sclerosis Society in America, is published in Nature Neuroscience.
Professor Charles ffrench-Constant, of the University of Edinburgh's MS Society Center for Multiple Sclerosis Research, said: "The aim of our research is to slow the progression of multiple sclerosis with the eventual aim of stopping and reversing it. This discovery is very exciting as it could potentially pave the way to find drugs that could help repair damage caused to the important layers that protect nerve cells in the brain."
Multiple sclerosis affects almost 100,000 people in the UK and several million worldwide. It often targets young adults between the ages of 20 and 40.
- 1 - Cladribine Significantly Reduces Brain Atrophy in Patients with Multiple Sclerosis : EMD Inc. (2017/02/13)
- 2 - New Multiple Sclerosis Treatment Clinical Trial Begins Enrollment : The Immune Tolerance Network; Benaroya Research Institute at Virginia Mason. (2020/01/07)
- 3 - Stigma Increases Risk of Depression for People with Multiple Sclerosis : Penn State (2018/03/01)
- 4 - Fumaric Acid Salts for Psoriasis May Help Multiple Sclerosis : Ruhr-University Bochum (2011/03/07)
- 5 - New Drug Cladribine for Multiple Sclerosis Shows Promise : Queen Mary, University of London (2010/01/20)
- 6 - Naltrexone Treats Multiple Sclerosis - But Sufferers Can't Get it : Cris Kerr (2009/02/27)
- 7 - $7M MS Progression Cohort to Research Multiple Sclerosis in Canada : Multiple Sclerosis Society of Canada (2017/03/31)
• Disabled World is strictly a news and information website provided for general informational purpose only and does not constitute medical advice. Materials presented are in no way meant to be a substitute for professional medical care by a qualified practitioner, nor should they be construed as such. Any 3rd party offering or advertising on disabled-world.com does not constitute endorsement by Disabled World.
• Please report outdated or inaccurate information to us.